Management of nightmares in patients with posttraumatic stress disorder: current perspectives.
Nat Sci Sleep November 26, 2018 DOI: 10.2147/nss.s166089 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractNightmares are a common and distressing symptom of posttraumatic stress disorder (PTSD). Current perspectives on managing these nightmares include both pharmacological and psychological approaches. Prazosin, an alpha-1 adrenergic receptor antagonist, is the most studied medication and has shown efficacy in reducing nightmare frequency and severity in some trials, though results are mixed. Psychological treatments, particularly imagery rehearsal therapy (IRT), are effective first-line interventions. Combining medication with psychotherapy may offer additional benefits. The review highlights the need for individualized treatment plans and further research to optimize outcomes.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Key finding | Both pharmacological (e.g., prazosin) and psychological (e.g., imagery rehearsal therapy) interventions are effective for managing PTSD-related nightmares, with combination therapy potentially offering added benefits. |
Abstract
Management of nightmares in patients with posttraumatic stress disorder: current perspectives.